news.alexionpharma.comPress Releases | Alexion Pharmaceuticals, Inc.
news.alexionpharma.com Profile
News.alexionpharma.com is a subdomain of alexionpharma.com, which was created on 2002-02-08,making it 23 years ago.
Description：The Investor Relations website contains information about Alexion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial...
Discover news.alexionpharma.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
news.alexionpharma.com Information
| HomePage size: 57.796 KB |
| Page Load Time: 0.250576 Seconds |
| Website IP Address: 204.237.221.136 |
news.alexionpharma.com Similar Website
| McElroy Press Room | News, Articles and Press Releases from McElroy |
| Press Room - KVH Industries | Press Releases | In the News |
| Primary Arms News & Press Releases - Primary Arms News & Press Releases |
| Ascension Press Newsroom - Press Releases for Ascension |
| Blizzard Press Center - Press releases |
| U. S. Steel - Press Room - Press Releases |
| Press Releases | Alexion Pharmaceuticals, Inc. |
| Tennessee Tourism Press Center | Press Releases and Media Kits |
| All News Releases and Press Releases from PRWeb |
| Heathrow Press Releases, Press Packs | Heathrow Media Centre |
| Global Press Releases - News, articles and press releases. |
| Goldgenie Press | For press releases, latest news and photos |
| Media newsroom – Here you will find all press releases, publications and key press |
| Rusty Taco Press Center – Resources that include press releases, bios, |
news.alexionpharma.com PopUrls
https://news.alexionpharma.com/press-release/product-news/alexion-receives-three-new-us-patents-soliris-eculizumab-extending-patent |
http://news.alexionpharma.com/press-release/company-news/alexion-acquire-wilson-therapeutics |
http://news.alexionpharma.com/press-release/company-news/alexion-acquires-taligen-therapeutics-and-creates-translational-medicine- |
http://news.alexionpharma.com/press-release/financial-news/alexion-present-upcoming-investor-conferences-2 |
https://news.alexionpharma.com/press-release/company-news/alexion-initiates-voluntary-nationwide-recall-certain-lots-soliris-eculiz |
http://news.alexionpharma.com/press-release/financial-news/alexion-present-goldman-sachs-healthcare-ceos-unscripted-conference |
https://news.alexionpharma.com/press-release/product-news/alexions-soliris-eculizumab-receives-marketing-approval-japan-all-patient |
https://news.alexionpharma.com/press-release/product-news/soliris%C2%A0eculizumab-inhibits-tma-and-improves-renal-function-pediatric-and |
http://news.alexionpharma.com/press-release/financial-news/alexion-present-cowen-and-company-38th-annual-health-care-conference |
https://news.alexionpharma.com/press-release/product-news/pnh-patients-treated-soliris-experienced-dramatic-reduction-blood-clots-d |
http://news.alexionpharma.com/press-release/financial-news/alexion-report-third-quarter-2017-results-thursday-october-26-2017 |
http://news.alexionpharma.com/press-release/company-news/alexion-employees-volunteer-together-enhance-their-local-communities-duri |
news.alexionpharma.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1584085760" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Fri, 13 Mar 2020 07:49:20 GMT |
| Link: https://ir.alexion.com/news-media/press-releases; rel="alternate"; hreflang="en", https://ir.alexion.com/news-media/press-releases; rel="canonical", https://ir.alexion.com/node/5816; rel="shortlink", https://ir.alexion.com/news-media/press-releases; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| Server: nginx |
| X-Age: 1245 |
| X-Cache-Hits: 23 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-26091e9e-64ff-11ea-a2ba-eb7736f6fa79 |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 11997 |
| X-EdgeConnect-MidMile-RTT: 42, 47 |
| X-EdgeConnect-Origin-MEX-Latency: 34, 34 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Fri, 13 Mar 2020 08:10:06 GMT |
| Date: Fri, 13 Mar 2020 08:10:06 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
news.alexionpharma.com Meta Info
| charset="utf-8"/ |
| content="Press Releases | Alexion Pharmaceuticals, Inc." name="title"/ |
| content="Alexion Pharmaceuticals, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="https://ir.alexion.com/news-media/press-releases" property="og:url"/ |
| content="Press Releases | Alexion Pharmaceuticals, Inc." property="og:title"/ |
| content="The Investor Relations website contains information about Alexion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="https://alexionpharmaceuticalsinc-redesign.gcs-web.com/sites/g/files/knoqqb49841/themes/site/nir_pid2144/dist/images/Alexion_logo_RGB_OG.jpg" property="og:image"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
news.alexionpharma.com Ip Information
| Ip Country: United States |
| City Name: Woodstock |
| Latitude: 39.3511 |
| Longitude: -76.8486 |
news.alexionpharma.com Html To Plain Text
We use cookies to give you the best online experience. By using our website, you agree to our use of cookies in accordance with our cookie policy . Contact Nav Contact Us Alexion.com Investor Relations Overview Financials Annual Reports SEC Filings News & Media Press Releases Featured Stories Media Materials Events & Presentations Stock Information Stock Quote & Chart Acquisitions Historical Lookup Investment Calculator IRS Disclosures Corporate Governance Corporate Governance Leadership Committee Composition Report a Concern Investor Relations Overview Financials Annual Reports SEC Filings News & Media Press Releases Featured Stories Media Materials Events & Presentations Stock Information Stock Quote & Chart Acquisitions Historical Lookup Investment Calculator IRS Disclosures Corporate Governance Corporate Governance Leadership Committee Composition Report a Concern Contact Nav Contact Us Alexion.com News & Media Press Releases Press Releases Search News Category Company Releases Company Statements Financial Releases Product Releases Year None 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Date Title PDF Version Mar 05, 2020 Alexion Announces Upcoming Data Presentations at 72nd Annual Meeting of the American Academy of Neurology Feb 27, 2020 Alexion Announces Launch of Alexion Charitable Foundation and Calls for Grantees Feb 26, 2020 Alexion to Present at the 40th Annual Cowen Health Care Conference Feb 20, 2020 Alexion to Present at the 9th Annual SVB Leerink Global Healthcare Conference Jan 30, 2020 Alexion Reports Fourth Quarter and Full Year 2019 Results Jan 28, 2020 Alexion Completes Acquisition of Achillion Jan 24, 2020 UPDATED TIME: Alexion Fourth Quarter and Full Year 2019 Results Conference Call at 7:30am ET on Thursday, January 30, 2020 Jan 17, 2020 Alexion to Report Fourth Quarter and Full Year 2019 Results on Thursday, January 30, 2020 Jan 14, 2020 Alexion Announces Planned Initiation of Pivotal Phase 3 Study of ULTOMIRIS® (ravulizumab) in ALS Jan 06, 2020 Alexion to Present at the 38th Annual J.P Morgan Healthcare Conference Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 1 - 10 of 559 Shareholder Tools Shareholder Tools Email Alerts RSS Print Share Inquiries insta Instagram Youtube Twitter LinkedIn RSS Close insta Footer Contact Us Legal Statement Privacy Notice Terms of Use This website is intended only for residents of the United States. © 2020 Alexion Pharmaceuticals,...
news.alexionpharma.com Whois
Domain Name: ALEXIONPHARMA.COM Registry Domain ID: 83470006_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2024-05-07T04:20:09Z Creation Date: 2002-02-08T17:50:14Z Registry Expiry Date: 2026-02-08T17:50:14Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1095.AWSDNS-08.ORG Name Server: NS-1989.AWSDNS-56.CO.UK Name Server: NS-376.AWSDNS-47.COM Name Server: NS-678.AWSDNS-20.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:52:18Z <<<